ANNX

Annexon, Inc.

• Reuters·50m ago

  Annexon CEO to present at Needham Virtual Healthcare Conference

• TipRanks·6d ago

  Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Annexon Biosciences (ANNX) and VolitionRX (VNRX)

• TipRanks·04/01 11:40

  Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), Ascendis Pharma (ASND)

• Simply Wall St·04/01 10:23

  Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

• TipRanks·04/01 06:04

  Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health

• Dow Jones·03/31 18:08

  Annexon Gains After 4Q Results, Drug Update

• TipRanks·03/31 17:10

  Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal

• Benzinga·03/31 13:57

  Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

• TipRanks·03/31 10:15

  Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating

• Reuters·03/31 10:09

  ANNEXON INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILING

• TipRanks·03/31 00:20

  Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Innovent Biologics (OtherIVBXF) and Sino Biopharmaceutical (OtherSBMFF)

• TipRanks·03/30 23:35

  Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating

• TipRanks·03/30 20:18

  Annexon reports Q4 EPS (28c), consensus (32c)

• Benzinga·03/30 20:06

  Annexon Q4 EPS $(0.28) Beats $(0.32) Estimate

• Reuters·03/30 20:04

  Annexon FY25 net loss widens 50.9% to $208.5 million; R&D expenses climb to $184.7 million